|
|
News for Healthier Living
PharmassetX Files Patent Application on New Form of Drug Substance from Green Tea
PharmassetX Inc., a late-preclinical stage pharmaceutical development company, today announced that the US Patent and Trademark Office has acknowledged receipt of the Company's patent application entitled "CRYSTALLINE FORM OF EPIGALLOCATECHIN-3-GALLATE." PharmassetX is developing the novel form of epigallocatechin gallate (EGCG) as a prescription drug for the treatment of inflammatory bowel disease (IBD).
November 18, 2024
November 23 2024November 22 2024November 21 2024November 20 2024 - Sylvester Cancer Tip Sheet - Nov 2024
- AI Speaks Volumes When It Comes to Detecting Parkinson's Disease
- Breaking Research Could Help to Advance Care for Overdose Patients Who've Taken Xylazine
- Human Cell Atlas Will Be 'Google Maps' for Health Research
- U.S. Postpartum Depression Diagnoses Doubled in a Decade
- Study Finds Disparities in Telemedicine Use for Neurological Conditions
- How Long Does It Take to Recover from "Brain on Fire" Disorder?
- More Than Half of U.S. Adults Could Benefit From GLP-1 Medications, Researchers Find
- Innovative Procedure Removes GI Tumors with Precision, No Incisions
- Guenther Offers Food Safety Advice for Successful Thanksgiving
- Over 4 Million US Adults with Chronic Liver Disease Can Be Grouped Into Unique Risk Groups Based on Barriers to Care
- Kappelman Leads Landmark Study Revealing That 100,000 American Youth Are Living with Inflammatory Bowel Disease
- California Child Tests Positive for Bird Flu
- Do This, Not That: How to Care for Your Child's Cast
- Study Reveals COVID-19's Impact on Global City Mobility
- Detecting Consciousness with EEGs, Soundscapes and ... Clowns
- The 2025 STS Annual Meeting - A Global Convening on Advances in Cardiothoracic Surgery
- New AI Tool Offers Insights to Improve Safety for Mothers and Babies in Maternity Care
- New Method Makes Brain Imaging Research More Accessible for Psychiatric Studies
- About 1 in 10 U.S. Adults Have High Cholesterol
- Four Million Americans Could Lose Health Coverage Once ACA Credits Expire
- Child-Teacher Bond in Early Education Could Have Lasting Impact
- Surgeon General Says U.S. Smoking Rates Have Tumbled, But Not for Everyone
- Earlier Type 2 Diabetes Diagnoses Bring Higher Odds for Dementia
- A-fib Plus Heart Failure a Dangerous Combo
- How Protective Antibodies Get in Malaria's Way
- Preterm Birth Associated with Increased Mortality Risk Into Adulthood, Study Finds
- Psychologists' Group Issues First Guidance to Parents on Teen Online Video Use
- Probiotic Delivers Anticancer Drug to the Gut
- Healthy Women Have Cells That Resemble Breast Cancer, Study Finds
- Updated Stroke Guidelines Focus on Women, Medications
- University Hospitals Only Health System in Northeast Ohio Offering FDA-Approved KISUNLA(tm) for Treatment of Alzheimer's Disease
- NPP Imaging Interpretation Share More Than Doubled between 2013 and 2022
- An Innovative Antibiotic for Drug-Resistant Bacteria
- Recycled Pacemakers Function as Well as New Devices, International Study Suggests
November 19 2024November 18 2024November 17 2024November 16 2024November 15 2024November 14 2024November 13 2024 - Community Partners Key to Success of Vaccine Clinic Focused on Neurodevelopmental Conditions
- McMaster University Researchers Uncover Potential Treatment for Rare Genetic Disorders
- Vaccine Shows Promise Against Aggressive Breast Cancer
- Chewing Xylitol Gum Linked to Decrease in Preterm Birth
- Researchers Reveal Why a Key Tuberculosis Drug Works Against Resistant Strains
- New Study Links Air Pollution with Increased Risk of Spontaneous Preterm Births
- Exposure to Marijuana in the Womb May Increase Risk of Addiction to Opioids Later in Life, Study Finds
- Treatment Advances, Predictive Biomarkers Stand to Improve Bladder Cancer Care
- Ozempic Could Help Curb Alcoholism
- AI Helps Spot Brain Tumor Tissue Surgeons Miss
- WashU Expert: 'X-odus' Creates Growing Challenges for Brand Marketing
- Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia
- Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & Exposition
- Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition - Tip Sheet
- Big Post-Election Surge Seen in Online Sales of Morning-After Pills
- MRI-Guided Radiation Therapy Reduces Long-Term Side Effects for Patients with Prostate Cancer
- Canadian Teen Hospitalized in Critical Condition With Bird Flu
- New Study Links Air Pollution with Higher Rates of Head and Neck Cancer
- Liquor, Wine, Beer: Which Comes With the Worst Lifestyle?
- Overtreatment Common for Older Men With Prostate Cancer
- Fatty Liver Disease Now Affects 4 in 10 U.S. Adults
- Good Night's Sleep Wards Off High Blood Pressure in Teens
- Telehealth Can Help Prevent Suicide in Those at High Risk
- Most Parents Don't Ask About Unlocked Guns in Homes Their Kids Visit
- Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories
- Harassment, Incivility, Disrespect in the Workplace Contributes to Anesthesia Workforce Shortage, Compromises Patient Safety
- Human Stem Cell-Derived Heart Cells Are Safe in Monkeys, Could Treat Congenital Heart Disease
- Pennsylvania Legislators to Address Xylazine Crisis at Free Medical Symposium
- New Discovery May Lead to More Effective Treatment for Cardiovascular Disease
- Fecal Microbiota Transplantation for Childhood Constipation and More in the November Issue of AJG
- An Advance Toward Inhalable mRNA Medications, Vaccines
- A Step Toward Safer X-Rays with New Detector Technology
- Which Risk Factors Are Linked to Having a Severe Stroke?
- The Study Explores the Impact of Sterilization Methods on Aronia Juice Quality
- Discovery of 2,586 Orphan Genes in Rosa Chinensis Provides Insights Into Stress Adaptation and Flower Development
- Most Parents Don't Ask About Firearms in the Homes Their Kids Visit
- KRISS Partners with Domestic University Hospitals to Develop Disease Diagnosis and Treatment Technology, Alleviating Patient Burden
November 12 2024November 11 2024November 10 2024November 9 2024
|
|
|
|
|